Followers | 29 |
Posts | 4738 |
Boards Moderated | 0 |
Alias Born | 12/27/2007 |
Friday, February 27, 2015 12:55:00 PM
IMHO roth resumes coverage soon with target of 10-13
For starters
VALUATION
Our standalone target price of $6 for OVRL is based on 1x EV/FY15 estimated revs of $114.4 million for OVRL excluding pending Sphere 3D merger. Based on the success of the combined OVRL-Tandberg-Sphere 3D company in synergistic storage and cloud/virtualization platforms, the stock may have upside potential longer-term. The combined Sphere 3D/OVRL company has upside potential depending on the success of the merged Sphere 3D and OVRL/Tandberg virtualization software and data storage and management platforms, operating and product/customer synergies with the deal, recent branded network-attached storage (NAS) product initiatives such as the SnapServer DX and SnapScale X2/X4 scale-out platforms, continued operating expense improvements, and software/storage/cloud virtualization platform offerings that leverage the global scale and OEM/channel partnerships established by OVRL and Tandberg Data. Impediments to our price target include: inability to close the Sphere 3D and OVRL deal, lower than expected sales due to macro weakness in enterprise/SMB IT spending, delays in ramping new product platforms such as V3 virtualization/ storage and server appliance, SnapServer DX/SnapScale clustered NAS solutions, lack of success with Sphere 3D to sell integrated storage/virtualization software appliances and cloud services.
Recent ANY News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 09:00:19 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/14/2024 09:31:39 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 11:22:03 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/12/2024 11:18:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 02:54:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/29/2024 10:15:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/26/2024 09:19:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 01:30:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:30:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 10:42:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:06:02 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:03:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 11:58:51 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/05/2024 09:15:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 09:19:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 01:30:27 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/03/2024 09:07:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 11:01:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 11:01:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:44:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:43:58 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/05/2023 09:37:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:21:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 01:04:52 AM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 11/17/2023 10:59:03 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM